Amundi Liva Nova PLC Transaction History

Amundi

$253 Billion
Q2 2024

A detailed history of Amundi transactions in Liva Nova PLC stock. As of the latest transaction made, Amundi holds 223,997 shares of LIVN stock, worth $11.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

223,997

Previous 232,412 3.62%

Holding current value

$11.8 Million

Previous $13 Million 5.55%

% of portfolio

0.0%

Previous 0.01%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$51.76 - $64.15 $435,560 - $539,822	-8,415 Reduced 3.62%	223,997 $12.3 Million
Q1 2024 May 15, 2024	BUY	$48.6 - $57.12 $3.31 Million - $3.89 Million	68,147 Added 41.49%	232,412 $13 Million
Q4 2023 Feb 14, 2024	SELL	$43.45 - $53.66 $213,991 - $264,275	-4,925 Reduced 2.91%	164,265 $8.5 Million
Q3 2023 Nov 14, 2023	BUY	$50.12 - $58.87 $73,175 - $85,950	1,460 Added 0.87%	169,190 $8.95 Million
Q2 2023 Aug 14, 2023	SELL	$42.28 - $51.43 $274,481 - $333,883	-6,492 Reduced 3.73%	167,730 $8.63 Million
Q1 2023 May 15, 2023	SELL	$40.84 - $58.14 $117,660 - $167,501	-2,881 Reduced 1.63%	174,222 $7.59 Million
Q4 2022 Feb 14, 2023	BUY	$43.88 - $56.16 $86,311 - $110,466	1,967 Added 1.12%	177,103 $9.84 Million
Q3 2022 Nov 14, 2022	SELL	$48.37 - $66.5 $151,639 - $208,477	-3,135 Reduced 1.76%	175,136 $9.02 Million
Q2 2022 Aug 15, 2022	SELL	$57.25 - $86.63 $729,994 - $1.1 Million	-12,751 Reduced 6.68%	178,271 $10.8 Million
Q1 2022 May 16, 2022	BUY	$71.02 - $86.99 $13.6 Million - $16.6 Million	191,022 New	191,022 $15.9 Million

Others Institutions Holding LIVN

# of Institutions

249

Shares Held

56.1M

Call Options Held

566K

Put Options Held

506K

View Full List

About LivaNova PLC

Ticker LIVN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 53,545,700
Market Cap $2.81B
Description
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...

More about LIVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amundi, based on Form 13F filings with the SEC.

News

Stay updated on Amundi with notifications on news.

Account